MISLABELED ORAL REHYDRATION SOLUTIONS IN INDIA: REGULATORY GAPS, PUBLIC HEALTH RISKS, AND THE WAY FORWARD

One of the most economical treatments for diarrheal illnesses is still oral rehydration therapy (ORT) with properly prepared oral rehydration salts (ORS). However, a growing number of ready-to-drink and liquid hydration drinks in India have been promoted or labeled as "ORS" despite not meeting the WHO-approved ORS's regulatory status, composition, or therapeutic indication. These mislabeled goods, which are frequently low in electrolyte content and rich in sugar, cause confusion, run the risk of being used inappropriately, exacerbate dehydration, particularly in children, and jeopardize public health initiatives. This paper describes how real ORS therapy has developed, details the Indian market and regulatory environment around mislabeled ORS-type goods, examines the phenomenon's effects on public health, and suggests professional, regulatory, and awareness-raising measures to reduce related hazards. To unify labeling practices, improve monitoring, and shield vulnerable populations from deceptive hydration products, immediate action is needed.